APPLICATION SITE AND GENDER DIFFERENCES IN PHARMACOKINETICS FOR A KETOROLAC TROMETHAMINE TRANSDERMAL DELIVERY SYSTEM

被引：0
|
作者：
COMBS, D [1 ]
MROSZCZAK, E [1 ]
JUAN, D [1 ]
IPE, D [1 ]
YU, S [1 ]
ROCHA, C [1 ]
机构：
[1] SYNTEX INC,DEV RES,PALO ALTO,CA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1995年 / 57卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：181 / 181
页数：1
相关论文
共 50 条
  • [21] Application of Full 32 Factorial Design in Formulation and Optimization of Hydrodynamically Balanced System of Ketorolac Tromethamine
    Asane, G. S.
    Ade, N. S.
    Bhoir, R. S.
    Kakad, S. B.
    V. Narsale, V.
    ASIAN JOURNAL OF PHARMACEUTICS, 2023, 17 (03) : 426 - 439
  • [22] Ocular Pharmacokinetics of 0.2% and 0.4% Ketorolac Tromethamine Formulated in DuraSite or DuraSite 2 Delivery Systems Compared to Acular LS in Rabbits
    Ee, Afshin Sha
    Bowman, Lyle
    Hou, Eddie
    Hosseini, Kamran
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [23] Pharmacokinetics of weekly transdermal estradiol controlled delivery system in postmenopausal Chinese
    Chen, GS
    Zhang, MY
    Wang, Q
    Ye, JC
    ACTA PHARMACOLOGICA SINICA, 1996, 17 (05): : 407 - 410
  • [24] Pharmacokinetics of a weekly transdermal delivery system of tenofovir alafenamide in hairless rats
    Jiang, Ying
    Gao, Xinyi
    Singh, Onkar N.
    Zhang, Wei
    Agrahari, Vivek
    Peet, M. Melissa
    Clark, Meredith R.
    Doncel, Gustavo F.
    Banga, Ajay K.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 582
  • [25] PHARMACOKINETICS OF PHYSOSTIGMINE IN MAN FOLLOWING A SINGLE APPLICATION OF A TRANSDERMAL SYSTEM
    WALTER, K
    MULLER, M
    BARKWORTH, MF
    NIECIECKI, AV
    STANISLAUS, F
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (01) : 59 - 63
  • [26] Transdermal testosterone gel: pharmacokinetics, efficacy of dosing and application site in hypogonadal men
    Meikle, AW
    Matthias, D
    Hoffman, AR
    BJU INTERNATIONAL, 2004, 93 (06) : 789 - 795
  • [27] Effects of application site and subject demographics on the pharmacokinetics of fentanyl HCl patient-controlled transdermal system (PCTS)
    Gupta, SK
    Hwang, S
    Southam, M
    Sathyan, G
    CLINICAL PHARMACOKINETICS, 2005, 44 (Suppl 1) : 25 - 32
  • [28] Effects of Application Site and Subject Demographics on the Pharmacokinetics of Fentanyl HCl Patient-Controlled Transdermal System (PCTS)
    Suneel K. Gupta
    Stephen Hwang
    Mary Southam
    Gayatri Sathyan
    Clinical Pharmacokinetics, 2005, 44 : 25 - 32
  • [29] The effect of site of application on the transcutaneous absorption of 17-β estradiol from a transdermal delivery system (Climara)
    Taggart, W
    Dandekar, K
    Ellman, H
    Notelovitz, M
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2000, 7 (05): : 364 - 369
  • [30] Pharmacokinetics of a 7-day 17 beta-estradiol transdermal delivery system: Effect of application site and repeated applications on serum concentrations of estradiol and estrone
    Boyd, RA
    Yang, BB
    Abel, RB
    Eldon, MA
    Sedman, AJ
    Forgue, ST
    JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (11): : 998 - 1005
12345